Hormonal Coc Spiro denied as non-formulary by Cigna?

Cigna's specific coverage criteria for hormonal coc spiro are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna May Deny a Combined COC + Spironolactone Regimen as Non-Formulary

A non-formulary denial means the specific product — either the combined oral contraceptive, the spironolactone formulation, or both — is not on Cigna's approved drug list for your plan tier, or is placed on a tier requiring additional review. Formularies change annually, and a drug that was covered last year may require a formulary exception this year.

Formulary exception requests are a well-established pathway. Cigna is required to have an exceptions process, and federal rules under ACA Section 2719 require plans to offer a medical exception when no therapeutically equivalent alternative exists on the formulary or when alternatives are contraindicated or clinically inappropriate for that patient.

## Your Federal Appeal Rights

You have two parallel tracks: a formulary exception request (often faster) and a formal internal appeal under ACA Section 2719 / ERISA Section 503. If both fail, you are entitled to independent external review through Cigna's designated IRO. The external review window is generally approximately four months from the final internal denial date. Expedited review is available when your health is at acute risk.

## Appeal Process and Timeline

1. Ask Cigna for the formulary exception form — this is the fastest first step. 2. Have your prescriber submit clinical justification explaining why the specific non-formulary agent is medically necessary and why formulary alternatives are not therapeutically equivalent. 3. File a formal internal appeal simultaneously or if the exception request is denied. 4. Request external review if both the exception and internal appeal fail.

## Documentation to Gather

• Diagnosis and clinical history: Chart notes establishing the condition being treated.
• Formulary alternative trial history: If Cigna's formulary has comparable agents, document that they were tried and failed, or explain why they are clinically inappropriate for this patient.
• Prescriber's medical-necessity and exception letter: Must specifically explain why the non-formulary product is required and why listed alternatives are inadequate — this is the single most important document.
• Prior treatment records: Dates, agents, and outcomes for any treatments already attempted.

## Criteria-Mapping Structure

Obtain Cigna's formulary exception criteria from the plan documents or by calling member services. Then map each requirement:

| Exception Criterion | Supporting Evidence | |---|---| | No therapeutically equivalent formulary alternative exists | Prescriber letter addressing each formulary alternative by name | | Alternative is contraindicated or clinically inappropriate | Chart documentation and prescriber attestation | | Medical necessity for specific non-formulary agent | Diagnosis records and clinical notes |

Confirm the FDA-approved prescribing label with your prescriber to ensure the requested formulation is appropriate for your diagnosis, and verify you are requesting the correct National Drug Code (NDC) to avoid administrative confusion in the resubmission.